Skip to main content
Clinical Trials/CTRI/2026/01/100815
CTRI/2026/01/100815Not yet recruitingNot Applicable

Association of serum cotinine level with cognitive function in chronic smokers

Maulana Azad Medical College1 site in 1 country80 target enrollmentStarted: January 26, 2026Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
80
Locations
1

Study Overview

Brief Summary

The primary aim of this study is to assess the association between serum cotinine levels and cognitive function in chronic tobacco smokers. Cognitive function will be evaluated using Addenbrooke’s Cognitive Examination-III, and serum cotinine along with other biochemical parameters will be measured and compared with age- and gender-matched healthy non-smokers.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
30.00 Year(s) to 55.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Group A: Chronic tobacco smokers between ages of 30 and 55 years smoking greater than 10 cigarette and or bidi per day for 10 years or more.
  • Group B: Age and gender matched healthy non smoker volunteers.

Exclusion Criteria

  • Any history of known psychiatric illness
  • Any medical condition or history of serious head injury that is known to influence cognition
  • History of using nicotine replacement therapy.
  • Recent history of alcohol consumption or any psychotropic medications or drugs (up to 3 months).

Investigators

Sponsor Class
Government medical college
Responsible Party
Principal Investigator
Principal Investigator

Dr Dhairya Rathod

Maulana Azad Medical College

Study Sites (1)

Loading locations...

Similar Trials